Detalles de la búsqueda
1.
Clinical outcomes with utilization of high-potency topical steroids in patients with lichen sclerosus-associated vulvar cancer.
Gynecol Oncol
; 187: 58-63, 2024 May 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38733953
2.
OVARIO phase II trial of combination niraparib plus bevacizumab maintenance therapy in advanced ovarian cancer following first-line platinum-based chemotherapy with bevacizumab.
Gynecol Oncol
; 166(2): 219-229, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35690498
3.
Optimal overall treatment time for adjuvant therapy for women with completely resected, node-positive vulvar cancer.
Gynecol Oncol
; 161(1): 63-69, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33500149
4.
Survival disparities in vulvar cancer patients in Commission on Cancer®-accredited facilities.
Gynecol Oncol
; 157(1): 136-145, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31954540
5.
Race-driven survival differential in women diagnosed with endometrial cancers in the USA.
Int J Gynecol Cancer
; 30(12): 1893-1901, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32847996
6.
Workplace Harassment and Discrimination in Gynecology: Results of the AAGL Member Survey.
J Minim Invasive Gynecol
; 26(5): 838-846, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30878643
7.
Does adjuvant chemotherapy dose modification have an impact on the outcome of patients diagnosed with advanced stage ovarian cancer? An NRG Oncology/Gynecologic Oncology Group study.
Gynecol Oncol
; 151(1): 18-23, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30135020
8.
Predictive modeling for determination of microscopic residual disease at primary cytoreduction: An NRG Oncology/Gynecologic Oncology Group 182 Study.
Gynecol Oncol
; 148(1): 49-55, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29174555
9.
What is the role of retroperitoneal exploration in optimally debulked stage IIIC epithelial ovarian cancer? An NRG Oncology/Gynecologic Oncology Group ancillary data study.
Cancer
; 123(6): 985-993, 2017 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27864921
10.
Genome-wide association study evaluating single-nucleotide polymorphisms and outcomes in patients with advanced stage serous ovarian or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study.
Gynecol Oncol
; 147(2): 396-401, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28935272
11.
Innovations in surgery and peri-operative care: A technical gimmick or true oncology advance?
Gynecol Oncol
; 161(1): 1-3, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33762085
12.
Evaluation of in vitro chemoresponse profiles in women with Type I and Type II epithelial ovarian cancers: An observational study ancillary analysis.
Gynecol Oncol
; 138(2): 267-71, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-26037898
13.
A cost-effectiveness analysis of a chemoresponse assay for treatment of patients with recurrent epithelial ovarian cancer.
Gynecol Oncol
; 136(1): 94-8, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25462203
14.
Impact of adjuvant chemotherapy with radiation for node-positive vulvar cancer: A National Cancer Data Base (NCDB) analysis.
Gynecol Oncol
; 137(3): 365-72, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25868965
15.
Cost-utility comparison of neoadjuvant chemotherapy versus primary debulking surgery for treatment of advanced-stage ovarian cancer in patients 65 years old or older.
Am J Obstet Gynecol
; 212(6): 763.e1-8, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25644442
16.
Adoption and impact of concurrent chemoradiation therapy for vaginal cancer: a National Cancer Data Base (NCDB) study.
Gynecol Oncol
; 135(3): 495-502, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25281493
17.
Impact of facility volume on therapy and survival for locally advanced cervical cancer.
Gynecol Oncol
; 132(2): 416-22, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24333361
18.
Oxaliplatin salvage for recurrent ovarian cancer: a single institution's experience in patient populations with platinum resistant disease or a history of platinum hypersensitivity.
Gynecol Oncol
; 134(1): 68-72, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24769036
19.
Corrigendum to "Does adjuvant chemotherapy dose modification have an impact on the outcome of patients diagnosed with advanced stage ovarian cancer? An NRG Oncology/Gynecologic Oncology Group study" [Gynecol. Oncol. 151 (2018) 18-23].
Gynecol Oncol
; 152(1): 220, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30360899
20.
The prognostic significance of pre- and post-treatment CA-125 in grade 1 serous ovarian carcinoma: a gynecologic Oncology Group study.
Gynecol Oncol
; 132(3): 560-5, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24333362